Last reviewed · How we verify
Anaferon
At a glance
| Generic name | Anaferon |
|---|---|
| Sponsor | Materia Medica Holding |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections (PHASE4)
- Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI (PHASE4)
- Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children (PHASE4)
- Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |